Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 25

1.

Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.

Sokol EA, Engelmann R, Kang W, Pinto N, Starkey A, Lai H, Nadel H, Shulkin BL, Pu Y, Appelbaum D, Yanik GA, Cohn SL, Armato SG 3rd, Volchenboum S.

Pediatr Blood Cancer. 2018 Sep 10:e27417. doi: 10.1002/pbc.27417. [Epub ahead of print]

PMID:
30198643
2.

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.

Sehdev A, Karrison T, Zha Y, Janisch L, Turcich M, Cohen EEW, Maitland M, Polite BN, Gajewski TF, Salgia R, Pinto N, Bissonnette MB, Fleming GF, Ratain MJ, Sharma MR.

Cancer Chemother Pharmacol. 2018 Aug;82(2):309-317. doi: 10.1007/s00280-018-3619-3. Epub 2018 Jun 9.

PMID:
29948021
3.

Admission to dedicated pediatric cardiac intensive care units is associated with decreased resource use in neonatal cardiac surgery.

Johnson JT, Wilkes JF, Menon SC, Tani LY, Weng HY, Marino BS, Pinto NM.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2606-2614.e5. doi: 10.1016/j.jtcvs.2018.01.100. Epub 2018 Feb 21.

PMID:
29550071
4.

Conceptualizing Post Intensive Care Syndrome in Children-The PICS-p Framework.

Manning JC, Pinto NP, Rennick JE, Colville G, Curley MAQ.

Pediatr Crit Care Med. 2018 Apr;19(4):298-300. doi: 10.1097/PCC.0000000000001476.

PMID:
29406379
5.

Neurodevelopmental Disorders in the PICU Population.

Sobotka SA, Peters S, Pinto NP.

Clin Pediatr (Phila). 2018 Jul;57(8):913-919. doi: 10.1177/0009922817737080. Epub 2017 Nov 2.

PMID:
29096537
6.

Long-Term Function After Pediatric Critical Illness: Results From the Survivor Outcomes Study.

Pinto NP, Rhinesmith EW, Kim TY, Ladner PH, Pollack MM.

Pediatr Crit Care Med. 2017 Mar;18(3):e122-e130. doi: 10.1097/PCC.0000000000001070.

PMID:
28107265
7.

Neuroblastoma survivors are at increased risk for second malignancies: A report from the International Neuroblastoma Risk Group Project.

Applebaum MA, Vaksman Z, Lee SM, Hungate EA, Henderson TO, London WB, Pinto N, Volchenboum SL, Park JR, Naranjo A, Hero B, Pearson AD, Stranger BE, Cohn SL, Diskin SJ.

Eur J Cancer. 2017 Feb;72:177-185. doi: 10.1016/j.ejca.2016.11.022. Epub 2016 Dec 26.

8.

Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.

Sokol E, Huang E, Pytel P, Cohn SL, Pinto N.

Pediatr Blood Cancer. 2017 Mar;64(3). doi: 10.1002/pbc.26226. Epub 2016 Sep 24. No abstract available.

PMID:
27663277
9.

Staphylococcus aureus ╬▒-Toxin Response Distinguishes Respiratory Virus-Methicillin-Resistant S. aureus Coinfection in Children.

Yu KO, Randolph AG, Agan AA, Yip WK, Truemper EJ, Weiss SL, Ackerman KG, Schwarz AJ, Giuliano JS Jr, Hall MW, Bubeck Wardenburg J; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) PICFlu Study Group; PALISI PICFlu Study Group.

J Infect Dis. 2016 Dec 1;214(11):1638-1646. Epub 2016 Sep 20.

10.

Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.

Pinto N, Mayfield JR, Raca G, Applebaum MA, Chlenski A, Sukhanova M, Bagatell R, Irwin MS, Little A, Rawwas J, Gosiengfiao Y, Delattre O, Janoueix-Lerosey I, Lapouble E, Schleiermacher G, Cohn SL.

Pediatr Blood Cancer. 2016 Jun;63(6):1019-23. doi: 10.1002/pbc.25934. Epub 2016 Feb 10.

11.

Second Malignant Neoplasms in Rhabdomyosarcoma: Victims of Our Own Success or an Underlying Genetic Predisposition Syndrome?

Pinto N, Hawkins DS.

Pediatr Blood Cancer. 2016 Feb;63(2):189-90. doi: 10.1002/pbc.25776. Epub 2015 Oct 27. No abstract available.

PMID:
26505490
12.

Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit.

Sakr Y, Alhussami I, Nanchal R, Wunderink RG, Pellis T, Wittebole X, Martin-Loeches I, Fran├žois B, Leone M, Vincent JL; Intensive Care Over Nations Investigators.

Crit Care Med. 2015 Dec;43(12):2623-32. doi: 10.1097/CCM.0000000000001310.

PMID:
26427591
13.

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.

Pinto NR, Applebaum MA, Volchenboum SL, Matthay KK, London WB, Ambros PF, Nakagawara A, Berthold F, Schleiermacher G, Park JR, Valteau-Couanet D, Pearson AD, Cohn SL.

J Clin Oncol. 2015 Sep 20;33(27):3008-17. doi: 10.1200/JCO.2014.59.4648. Epub 2015 Aug 24. Review.

14.

Associations Between Day of Admission and Day of Surgery on Outcome and Resource Utilization in Infants With Hypoplastic Left Heart Syndrome Who Underwent Stage I Palliation (from the Single Ventricle Reconstruction Trial).

Johnson JT, Sleeper LA, Chen S, Ohye RG, Gaies MG, Williams IA, Sachdeva R, Pruetz JD, Tatum GH, Thacker D, Brunetti MA, Frommelt MA, Jacobs JP, Kirsh JA, Lambert LM, Newburger JW, Pemberton VL, Zyblewski SC, Divanovic AA, Pinto NM; Pediatric Heart Network Investigators.

Am J Cardiol. 2015 Oct 15;116(8):1263-9. doi: 10.1016/j.amjcard.2015.07.044. Epub 2015 Jul 29.

15.

Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.

Darlington WS, Pinto N, Hecktman HM, Cohn SL, LaBelle JL.

Pediatr Blood Cancer. 2015 Dec;62(12):2232-4. doi: 10.1002/pbc.25650. Epub 2015 Jul 14.

PMID:
26174546
16.

Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience.

Pinto N, Volchenboum SL, Skol AD, Rhodes L, Doan A, Fein-Levy C, Lipton JM, Cunningham JM, Onel K.

Per Med. 2015 Jun;12(3):221-229. doi: 10.2217/pme.14.90.

PMID:
29771652
17.

Case report: Inability to achieve a therapeutic dose of tacrolimus in a pediatric allogeneic stem cell transplant patient after generic substitution.

Madian AG, Panigrahi A, Perera MA, Pinto N.

BMC Pharmacol Toxicol. 2014 Dec 3;15:69. doi: 10.1186/2050-6511-15-69.

18.

Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.

Applebaum MA, Henderson TO, Lee SM, Pinto N, Volchenboum SL, Cohn SL.

Pediatr Blood Cancer. 2015 Jan;62(1):128-33. doi: 10.1002/pbc.25249. Epub 2014 Sep 23.

19.

Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patients.

Pinto N, Gamazon ER, Antao N, Myers J, Stark AL, Konkashbaev A, Im HK, Diskin SJ, London WB, Ludeman SM, Maris JM, Cox NJ, Cohn SL, Dolan ME.

Clin Pharmacol Ther. 2014 Jun;95(6):644-52. doi: 10.1038/clpt.2014.37. Epub 2014 Feb 18.

20.

Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.

Pinto N, Cipkala DA, Ladd PE, Pu Y, Cohn SL.

Pediatr Blood Cancer. 2014 Jun;61(6):1104-6. doi: 10.1002/pbc.24889. Epub 2013 Nov 30.

PMID:
24293072

Supplemental Content

Loading ...
Support Center